A Study of Hormonal Therapy and Apalutamide With or Without Abiraterone Acetate and Prednisone in Newly Diagnosed Prostate Cancers

Condition:   Prostate Cancer Interventions:   Drug: Apalutamide;   Drug: Abiraterone Acetate;   Drug: Prednisone;   Procedure: Radical Prostatectomy;   Procedure: Extended Pelvic lymphadenectomy;   Drug: GnRH agonist/antagonist Sponsors:   Memorial Sloan Kettering Cancer Center;   Dana-Farber Cancer Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials